The global AI Lung Ultrasound Solution market size is predicted to grow from US$ 283 million in 2025 to US$ 1310 million in 2032; it is expected to grow at a CAGR of 24.5% from 2026 to 2032.

AI Lung Ultrasound Solution is a software-centric clinical decision support system designed to assist clinicians in assessing pulmonary conditions by analyzing lung ultrasound (LUS) images and cine loops. Unlike CT-based screening, these solutions leverage point-of-care ultrasound to identify and quantify sonographic patterns such as B-lines, pleural line abnormalities, consolidations, and effusions, supporting triage, monitoring, and follow-up in emergency, critical care, respiratory, and primary-care settings. The solution typically includes AI inference software, workflow integration with ultrasound devices, and standardized reporting modules; it may be embedded directly on ultrasound machines (edge-AI) or deployed via cloud or on-premise servers. Clinical value centers on radiation-free, repeatable bedside assessment, rapid decision support, and improved inter-operator consistency in settings where CT access is limited or time-critical.

From a multi-angle segmentation and parameterization perspective, the market can be classified by: (1) Clinical use caseacute care triage (e.g., pneumonia, pulmonary edema), longitudinal monitoring (ICU, heart failure), or outpatient screening; (2) AI functionspattern detection, region-level scoring, severity quantification, and trend analysis; (3) Deployment modelon-device/edge, private cloud, public cloud/SaaS, or hybrid; (4) Integration depthstandalone app vs OEM-embedded modules within ultrasound consoles; and (5) User typephysicians, nurses, or sonographers. Key quantitative parameters include supported probe types, frame rate and cine length, sensitivity/specificity at predefined thresholds, scoring granularity, processing latency, and interoperability standards.

The industry value chain begins upstream with ultrasound hardware OEMs, probe and semiconductor suppliers, and compute providers. Midstream players develop AI models, annotation pipelines, and clinical validationoften in partnership with hospitals and academic centers to capture diverse LUS datasets. Downstream customers include hospitals, emergency departments, ICUs, outpatient clinics, and home-care programs. Cost structures are dominated by R&D and clinical validation, regulatory compliance, software integration, and ongoing model maintenance. As a predominantly software product, AI Lung Ultrasound solutions typically achieve high gross margins (often ~6585%) at scale, although early deployments may see margin pressure from customization, training, and support.

In commercial transactions, pricing commonly follows per-device or per-site subscriptions, usage-based fees, or OEM licensing bundled with ultrasound systems; pilot studies frequently precede multi-year contracts. Market momentum is driven by the expansion of point-of-care ultrasound, workforce shortages, and demand for rapid, low-cost respiratory assessment. Emerging trends include deeper OEM embedding, multimodal fusion with clinical data, broader regulatory clearances, and expansion from COVID-era applications toward chronic disease management and routine respiratory carepositioning AI Lung Ultrasound as a scalable complement to CT-based pathways.

Infinity Market Research newest research report, the AI Lung Ultrasound Solution Industry Forecast looks at past sales and reviews total world AI Lung Ultrasound Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected AI Lung Ultrasound Solution sales for 2026 through 2032. With AI Lung Ultrasound Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Lung Ultrasound Solution industry.

This Insight Report provides a comprehensive analysis of the global AI Lung Ultrasound Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Lung Ultrasound Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global AI Lung Ultrasound Solution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Lung Ultrasound Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Lung Ultrasound Solution.

This report presents a comprehensive overview, market shares, and growth opportunities of AI Lung Ultrasound Solution market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Handheld Ultrasound + Embedded AI
    Cart-based Ultrasound + AI Modules
    Others
    Segmentation by AI Functional Capability:
    Anatomical Guidance & Probe Positioning
    Pattern Recognition Systems
    Quantitative Scoring Systems
    Others
    Segmentation by Deployment & Connectivity Model:
    On-premise
    Private Cloud (Hospital-owned Cloud)
    Public Cloud / SaaS
    Others

Segmentation by Application:

    Hospital
    Clinic
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Butterfly Network
    DiA Imaging
    Exo Imaging
    GE Healthcare
    Philips
    Canon Medical
    Lianying Intelligent Medical Technology